Evaluating burnout among clinical pharmacists across 23 governorates in Egypt: a cross-sectional study Mohamed Hendawy, Mohamed Abouzid, Heba Elshazly, Ali Ahmed Ali Ismeal, Mahmoud Elazb, et al. BMC Psychology, 2026 Background The growth in services provided by clinical pharmacists in Egypt and their collaborative work with physicians contribute to enhancing patient safety and realizing favorable clinical outcomes. Several studies highlighted that clinical pharmacists may be susceptible to burnout. Hence, we are conducting this study due to a lack of research evaluating the prevalence of burnout among clinical pharmacists in Egypt. Methods We conducted a cross-sectional study on clinical pharmacists in Egypt from October 2022 to January 2023. The questionnaire included demographic characteristics and Copenhagen Burnout Inventory (CBI). A p -value less than 0.05 was considered statistically significant in all tests. Results Two hundred twenty-two clinical pharmacists filled out the survey, 75% had moderate and above burnout levels (CBI ≥ 50). Three multivariate models were built to explore burnout across personal, work-related, and patient-related domains. Our key findings indicate that individuals facing financial strain (insufficient income and debt) are significantly more likely to experience higher burnout. Additionally, those with a master's degree (compared to a bachelor's in pharmacy) are more prone to work-related burnout. Furthermore, an association exists between more years of experience and elevated levels of both work and personal burnout. Lastly, direct patient contact and being female are linked to higher personal burnout. In terms of univariate predictors for high overall burnout (CBI ≥ 75), more years of experience and being in debt are significantly associated with higher odds of burnout (with odds ratios of 1.08 and 6.00, respectively). The back stepwise regression model reinforces the impact of years of experience, suggesting that for each additional year of experience, the odds of high burnout increase by approximately 8.4% Conclusion The prevalence of burnout among clinical pharmacists is high. Demographic characteristics may significantly influence burnout levels within specific domains. Notably, pharmacists with more years of experience are more likely to experience high burnout. These findings are alarming and warrant further investigation. Proper interventions are needed to identify the reasons behind this trend among more experienced pharmacists. By identifying these factors, we can develop effective strategies to mitigate burnout and promote well-being in this group of professional healthcare providers. Graphical Abstract Information was collected from 222 clinical pharmacists across 32 governorates in Egypt. The names of the governorates are displayed on the left side, with each color representing a different governorate. The frequency of responses from each governorate is indicated by columns on the map; the taller the column, the higher the frequency from that governorate. Demographic data is also represented, including gender (female and male), residency (rural or urban), highest education level (Doctorate, PhD; Master, MSc; or Bachelor, BSc), and income status($, Not enough and in debt; $$, Not enough; $$$, Just enough; or $$$$, Enough and can save). We also represented the average age (in years), experience (in years), and Copenhagen Burnout Inventory average scores for each domain for all responders.
Healthcare access and barriers in Jordan: Insights from a Nationwide Survey Yazan A. Al-Ajlouni, Mohammed Ayyad, Mohammad Tanashat, Omar Al Ta’ani, Hebah AlMomani, et al. Plos One, 2026 Background Healthcare access disparities are a significant public health concern, particularly in low- and middle-income countries like Jordan. Despite advancements in healthcare infrastructure, barriers such as financial constraints, cultural norms, and logistical challenges persist, exacerbated by the influx of refugees. This study evaluates the influence of demographic, socioeconomic, and health-related factors on healthcare access and utilization in Jordan, aiming to identify specific barriers and disparities. Methods A nationwide survey was conducted in April 2024 using Facebook for recruitment, with 908 eligible participants aged 18–65 completing the survey. Data on healthcare access, barriers, and demographic variables were collected using a validated questionnaire. Statistical analyses included chi-squared tests and Kruskal-Wallis tests to assess differences in healthcare access across subgroups. Results Marital status significantly influenced healthcare access, with never-married individuals reporting better access to immediate and specialist care compared to married participants. Employment status revealed disparities, as students had better access to immediate and specialist care, while retired individuals had better access to routine check-ups. Self-reported health status was strongly associated with healthcare access, as individuals reporting excellent health experienced fewer delays and demonstrated higher trust in providers. Barriers to healthcare access included financial constraints, time limitations, and fear of diagnosis, while surgical access challenges centered on cost and waiting times. Conclusions Significant disparities in healthcare access exist in Jordan, driven by demographic and socioeconomic factors. Addressing these challenges requires policy reforms, digital health integration, and enhanced public-private partnerships to improve equity and reduce barriers.
Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021 Yi Deun Jeong, Seoyoung Park, Wonwoo Jang, Min Seo Kim, A Bhoomadevi, et al. Korean Journal of Internal Medicine, 2026 Background/Aims: This study aims to evaluate the global burden of adverse effects of medical treatment (AEMT) using data from the Global Burden of Disease Study (GBD) 2021.Methods: Data were extracted from the GBD 2021, covering 204 countries/territories from 1990 to 2021. AEMT was defined using ICD-9 and ICD-10 codes, encompassing complications from medical procedures, treatments, or healthcare exposures. Estimates were categorized into fatal and non-fatal outcomes and stratified by age, sex, year, and covariates, including the Socio-demographic Index (SDI). Mortality-incidence ratios (MIRs), defined as the ratio of mortality calculated by dividing the number of deaths by the total incident cases, were analyzed.Results: In 2021, the global age-standardized prevalence, incidence, disability-adjusted life years (DALYs), and mortality rates of AEMT were 11.48 (95% uncertainty interval [UI], 8.86–14.13), 150.44 (131.19–171.81), 64.19 (51.06–73.11), and 1.53 (1.29–1.68) per 100,000 population, respectively. DALY rates were highest in the early neonatal group (4,789.47 per 100,000 population [95% UI, 3,682.00–5,963.30]), while mortality rates followed a U-shaped pattern across age groups. In 2021, MIRs were highest at both ends of the age range: the early neonatal group (0.58 [95% UI, 0.55–0.58]) and the 95+ age group (0.05 [0.04–0.06]). This pattern was consistent across all SDI quintiles, with higher MIRs observed in lower SDI quintiles.Conclusions: The significantly higher prevalence and incidence rates of AEMT among the older population in high SDI quintiles, compared to lower SDI quintiles, could be attributed to the healthcare overutilization, highlighting the need for policy adjustments.
Efficacy of Azithromycin for Preventing Chronic Lung Disease of Prematurity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials O Altobaishat, E Balbaa, M Arnaout, HA Ahmad, HA Suilik, A Sharaf, ... Current Pharmacology Reports 12 (1), 17 , 2026 2026
Public perceptions of heroin use: the influence of smoking, marital, and employment status on stigma toward people who use substances YA Al-Ajlouni, M Tanashat, DA Omari, M Abouzid, S Shdeifat, R Bajali, ... Substance Abuse Treatment, Prevention, and Policy 21 (1), 6 , 2026 2026
ABSTRACT NUMBER: ESOC2026A603 ROBOT-ASSISTED STEREOTACTIC SURGERY FOR INTRACEREBRAL HEMORRHAGE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SAFETY AND EFFICACY N Al-Dardery, M Elfakhrany, S Alqato, M El-Samahy, S Batarseh, ... European Stroke Journal 11 (Suppl 1), i216 , 2026 2026
ABSTRACT NUMBER: ESOC2026A2251 STRETCHING THE CLOCK: REASSESSING INTRAVENOUS THROMBOLYSIS BEYOND 4.5 HOURS IN ACUTE ISCHEMIC STROKE—A META-ANALYSIS OF OVER 50,000 PATIENTS MHED Moawad, I Serag, M Abouzid European Stroke Journal 11 (Suppl 1), i587 , 2026 2026
ABSTRACT NUMBER: ESOC2026YS26 THERAPEUTIC EFFICACY AND SAFETY OF ESCITALOPRAM FOR POST-STROKE DEPRESSION: EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS I Serag, M Moawad, M Abouzid European Stroke Journal 11 (Supplement_1), i643-i643 , 2026 2026
ABSTRACT NUMBER: ESOC2026A439 OPTIMIZING SURGICAL AND PERIOPERATIVE STRATEGIES IN CHRONIC SUBDURAL HEMATOMA: AN UMBRELLA REVIEW AND META-ANALYTIC EVIDENCE TO GUIDE CONTEMPORARY … I Serag, M Abouzid European Stroke Journal 11 (Supplement_1), i730-i730 , 2026 2026
ABSTRACT NUMBER: ESOC2026A200 INTRAVENOUS TIROFIBAN AS AN ADJUNCT THERAPY FOR ACUTE ISCHEMIC STROKE PATIENTS EXPERIENCING NEUROLOGICAL WORSENING: A META-ANALYSIS OF THERAPEUTIC … M Moawad, I Serag, I Alkhawaldeh, M Abouzid European Stroke Journal 11 (Supplement_1), i130-i131 , 2026 2026
ABSTRACT NUMBER: ESOC2026A2260 ANALYZING THE EFFECTS OF ANEMIA ON THE OUTCOMES OF MECHANICAL THROMBECTOMY IN ISCHEMIC STROKE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS I Serag, M Abouzid, M Moawad European Stroke Journal 11 (Supplement_1), i589-i590 , 2026 2026
ABSTRACT NUMBER: ESOC2026A201 SAFETY AND EFFICACY OF PATIENT-CENTERED CARE VERSUS USUAL CARE FOR POST STROKE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED … I Serag, M Moawad, M Abouzid European Stroke Journal 11 (Supplement_1), i10-i10 , 2026 2026
Back Pain in Lebanon: A Cross-sectional Study of Ergonomic Awareness, Lifestyle Factors, and Preventive Behaviors in a Nationally Representative Sample M Tanashat, N Fakih, MA Al-Akash, S Al-Aomar, M Abouzid, N El Bizri, ... Archives of Physical Medicine and Rehabilitation 107 (5), e116 , 2026 2026
Analyzing the effects of anemia on the outcomes of mechanical thrombectomy in ischemic stroke patients: a systematic review and meta-analysis MHED Moawad, I Serag, IM Alkhawaldeh, AF Gadelmawla, ... Annals of Medicine and Surgery 88 (5), 2888-2896 , 2026 2026
26-A-7896-ACC AI-ASSISTED ECHOCARDIOGRAPHY FOR DETECTING LEFT VENTRICULAR DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS A Ramadan, M Soliman, RR Gangavarapu, S Mehta, MR Maddi, ... Journal of the American College of Cardiology 87 (13_Supplement), A1195-A1195 , 2026 2026
Knowledge and attitudes toward mpox among the Lebanese population during the second wave and their attitudes toward vaccination M Tanashat, N Fakih, N El Bizri, M Saad Rakab, M Abouzid, K Sleiman, ... Scientific Reports , 2026 2026
Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 LM Force, JM Kocarnik, ML May, K Bhangdia, A Crist, L Penberthy, ... The Lancet 407 (10536), 1360-1373 , 2026 2026 Citations: 3
Exercise as a Non-Pharmacological Therapeutic Strategy in Breast Cancer: An Umbrella Review of Systematic Reviews and Meta-Analyses M Hendawy, M Abouzid, AZ Alnajjar, M Elnagar, FM Rzk, JM Daniel, ... Journal of Medical Science 95 (1), e1320-e1320 , 2026 2026
Healthcare access and barriers in Jordan: Insights from a Nationwide Survey YA Al-Ajlouni, M Ayyad, M Tanashat, O Al Ta’ani, H AlMomani, J Nusier, ... Plos one 21 (3), e0345456 , 2026 2026
Author Correction: Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study J Oh, S Kim, Y Yim, MS Kim, SI Hay, J Il Shin, DK Yon nature medicine, 1-1 , 2026 2026
The burden of digestive diseases in Jordan: a longitudinal analysis of Global Burden of Disease Study, 1990–2021 O Altobaishat, Y Khlidj, O Abdullah Bataineh, O Alzoubi, M Adam, ... Baylor University Medical Center Proceedings 39 (2), 212-225 , 2026 2026 Citations: 1
Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021 GBD 2021 AEMT Collaborators The Korean Journal of Internal Medicine 41 (2), 350 , 2026 2026
Antiplatelet dilemma: Clopidogrel or aspirin for long-term cardiovascular protection after dual antiplatelet therapy following PCI MHED Moawad, M Elsayed, I Serag, RM Wagih, A Elgharabawi, Y Ahmed, ... Medicine 105 (9), e47773 , 2026 2026
MOST CITED SCHOLAR PUBLICATIONS
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … GBD 2021 Causes of Death Collaborators Lancet (London, England) 403 (10440), 2100 , 2024 2024 Citations: 2713
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203 , 2024 2024 Citations: 2544
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003 , 2024 2024 Citations: 1335
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256 , 2024 2024 Citations: 1103
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056 , 2024 2024 Citations: 956
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099 , 2024 2024 Citations: 395
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 M Naghavi, HH Kyu, MA Aalipour, H Aalruz, HS Ababneh, BJ Abafita, ... The Lancet 406 (10513), 1811-1872 , 2025 2025 Citations: 314
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational … SI Hay, KL Ong, DF Santomauro, MA Aalipour, H Aalruz, HS Ababneh, ... The Lancet 406 (10513), 1873-1922 , 2025 2025 Citations: 284
Thermochemical conversion strategies of biomass to biofuels, techno-economic and bibliometric analysis: a conceptual review AM Elgarahy, A Hammad, DM El-Sherif, M Abouzid, MS Gaballah, ... Journal of Environmental Chemical Engineering 9 (6), 106503 , 2021 2021 Citations: 167
Telehealth and Artificial Intelligence insights into healthcare during the COVID-19 pandemic DM El-Sherif, M Abouzid, MT Elzarif, AA Ahmed, A Albakri, MM Alshehri Healthcare 10 (2), 385 , 2022 2022 Citations: 159
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease … E Haeuser, S Byrne, J Nguyen, C Raggi, SA McLaughlin, C Bisignano, ... The Lancet 406 (10500), 235-260 , 2025 2025 Citations: 132
Gelatin nanofibers: Recent insights in synthesis, bio-medical applications and limitations HR El-Seedi, NS Said, N Yosri, HB Hawash, DM El-Sherif, M Abouzid, ... Heliyon 9 (5) , 2023 2023 Citations: 132
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for … AE Schumacher, P Zheng, RM Barber, MA Aalipour, H Aalruz, ... The Lancet 406 (10513), 1731-1810 , 2025 2025 Citations: 112
Influence of COVID-19 on lifestyle behaviors in the Middle East and North Africa Region: a survey of 5896 individuals M Abouzid, DM El-Sherif, NK Eltewacy, NBH Dahman, SA Okasha, ... Journal of translational medicine 19 (1), 129 , 2021 2021 Citations: 99
Deep learning approaches in histopathology AA Ahmed, M Abouzid, E Kaczmarek Cancers 14 (21), 5264 , 2022 2022 Citations: 97
Environmental risk, toxicity, and biodegradation of polyethylene: a review DM El-Sherif, MG Eloffy, A Elmesery, M Abouzid, M Gad, HR El-Seedi, ... Environmental Science and Pollution Research 29 (54), 81166-81182 , 2022 2022 Citations: 82
Hydrogen production from wastewater, storage, economy, governance and applications: a review AM Elgarahy, MG Eloffy, A Hammad, AN Saber, DM El-Sherif, A Mohsen, ... Environmental Chemistry Letters 20 (6), 3453-3504 , 2022 2022 Citations: 69
Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study S Lee, Y Son, J Hwang, MS Kim, J Il Shin, DK Yon, NJ Kassebaum Nature Medicine 31 (6), 1809-1829 , 2025 2025 Citations: 51
Genetic determinants of vitamin D-related disorders; focus on vitamin D receptor M Abouzid, M Karazniewicz-Lada, F Glowka Current drug metabolism 19 (12), 1042-1052 , 2018 2018 Citations: 49
Analysis of mHealth research: mapping the relationship between mobile apps technology and healthcare during COVID-19 outbreak DM El-Sherif, M Abouzid Globalization and Health 18 (1), 67 , 2022 2022 Citations: 48